Rani Therapeutics
RANI
RANI
28 hedge funds and large institutions have $29.1M invested in Rani Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 0 closing their positions.
Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
9
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$1.16M |
| 2 |
TWA
2
TPB Wealth Advisors
San Antonio,
Texas
|
$742K |
| 3 |
3
BlackRock
New York
|
$2.14M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$3.44M |
| 5 |
CCM
5
Crossvault Capital Management
San Antonio,
Texas
|
$148K |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$111K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$12K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$26K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$22K |
| 5 |
5
Osaic Holdings
Scottsdale,
Arizona
|
$196K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $4K | 377 | -45 | -11% |
|
27
Daiwa Securities Group
Tokyo,
Japan
| $1K | 58 | – | – |
|
|
CFGS
28
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 27 | – | – |
|